Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs

Vaccine - Tập 31 - Trang 2692-2697 - 2013
Stephanie Donauer1, Daniel C. Payne2, Kathryn M. Edwards3, Peter G. Szilagyi4, Richard W. Hornung5, Geoffrey A. Weinberg4, James Chappell6, Caroline B. Hall4, Umesh D. Parashar2, Mary Allen Staat7
1Division of Biostatistics and Epidemiology, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States
2Epidemiology Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, United States
3Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States
4Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States
5Division of Emergency Medicine, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States
6Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States
7Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States

Tài liệu tham khảo

Parashar, 2003, Global illness and deaths caused by rotavirus disease in children, Emerg Infect Dis, 9, 565, 10.3201/eid0905.020562 Fischer, 2007, Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993–2003, J Infect Dis, 195, 1117, 10.1086/512863 Parashar, 1998, Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code, J Infect Dis, 177, 13, 10.1086/513808 Charles, 2006, Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993–2002, Pediatr Infect Dis J, 25, 489, 10.1097/01.inf.0000215234.91997.21 Malek, 2006, Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000, Pediatrics, 117, 1887, 10.1542/peds.2005-2351 Tate, 2011, Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data, Pediatr Infect Dis J, 30, S56, 10.1097/INF.0b013e3181fefdc0 Staat, 2010, Estimating the rotavirus hospitalization disease burden and trends, using capture-recapture methods, Pediatr Infect Dis J, 29, 1083, 10.1097/INF.0b013e3181fb8f7b Tate, 2011, Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006, Pediatr Infect Dis J, 30, S30, 10.1097/INF.0b013e3181ffe3eb Yen, 2011, Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction, Pediatrics, 127, e9, 10.1542/peds.2010-1393 Reduction in rotavirus after vaccine introduction – United States, 2000–2009. MMWR – Morbidity and mortality weekly report. 2009;58(October (41)):1146–9. Payne, 2011, Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006–2009, Clin Infect Dis, 53, 245, 10.1093/cid/cir307 Delayed onset and diminished magnitude of rotavirus activity – United States, November 2007–May 2008. MMWR – Morbidity and mortality weekly report 2008;57(June (25)):697–700. Parashar, 2006, Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 55, 1 Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics 2007;119(January (1)):171–82. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics 2009;123(May (5)):1412–20. Orenstein, 1988, Assessing vaccine efficacy in the field. Further observations, Epidemiol Rev, 10, 212, 10.1093/oxfordjournals.epirev.a036023 Eisenberg, 2008, Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003–2004 and 2004–2005 influenza seasons, Pediatrics, 122, 911, 10.1542/peds.2007-3304 Jick, 2010, Measles in the United Kingdom 1990–2008 and the effectiveness of measles vaccines, Vaccine, 28, 4588, 10.1016/j.vaccine.2010.04.084 Harling, 2005, The effectiveness of the mumps component of the MMR vaccine: a case control study, Vaccine, 23, 4070, 10.1016/j.vaccine.2004.10.020 Whitney, 2006, Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study, Lancet, 368, 1495, 10.1016/S0140-6736(06)69637-2 Boom, 2010, Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States, Pediatrics, 125, e199, 10.1542/peds.2009-1021 Guh, 2011, Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006–2008, Vaccine, 29, 6155, 10.1016/j.vaccine.2011.06.066 Staat, 2011, Effectiveness of pentavalent rotavirus vaccine against severe disease, Pediatrics, 128, e267, 10.1542/peds.2010-3722 Bisgard, 2005, Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998–2001, Pediatrics, 116, e285, 10.1542/peds.2004-2759 Breslow, 1996, Statistics in epidemiology: the case-control study, Journal of the American Statistical Association, 91, 14, 10.1080/01621459.1996.10476660 Gilca, 2011, Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children, Pediatrics, 128, e1084, 10.1542/peds.2010-3492 Cortese, 2011, Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine, Pediatrics, 128, e1474, 10.1542/peds.2011-1006 Kalies, 2004, Pediatr Infect Dis J, 23, 944, 10.1097/01.inf.0000141743.74443.73 Kalies, 2008, Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure, Vaccine, 26, 2545, 10.1016/j.vaccine.2008.03.001 Szilagyi, 2008, Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study, Arch Pediatr Adolesc Med, 162, 943, 10.1001/archpedi.162.10.943 Moulton, 2000, Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population, Int J Epidemiol, 29, 753, 10.1093/ije/29.4.753 Prentice, 1986, A case-cohort design for epidemiologic cohort studies and disease prevention trials, Biometrika, 73, 1, 10.1093/biomet/73.1.1 Thompson, 2011, The pregnancy and influenza project: design of an observational case-cohort study to evaluate influenza burden and vaccine effectiveness among pregnant women and their infants, Am J Obstet Gynecol, 204, S69, 10.1016/j.ajog.2011.01.006 Payne, 2008, Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States, Pediatrics, 122, 1235, 10.1542/peds.2007-3378 Payne, 2009, Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program, Pediatr Infect Dis J, 28, 948, 10.1097/INF.0b013e3181a6ad6e Gouvea, 1990, Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens, J Clin Microbiol, 28, 276, 10.1128/JCM.28.2.276-282.1990 Gentsch, 1992, Identification of group A rotavirus gene 4 types by polymerase chain reaction, J Clin Microbiol, 30, 1365, 10.1128/JCM.30.6.1365-1373.1992 Griffin, 2002, Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6],G12) and rare P3[9] strains related to bovine rotaviruses, Virology, 294, 256, 10.1006/viro.2001.1333 Das, 1994, Characterization of rotavirus strains from newborns in New Delhi, India, J Clin Microbiol, 32, 1820, 10.1128/JCM.32.7.1820-1822.1994 Levy, 1999 Poehling, 2006, The underrecognized burden of influenza in young children, N Engl J Med, 355, 31, 10.1056/NEJMoa054869 Neuzil, 2000, The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children, N Engl J Med, 342, 225, 10.1056/NEJM200001273420401 Iwane, 2004, Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children, Pediatrics, 113, 1758, 10.1542/peds.113.6.1758 Binder, 1992, Fitting Cox's proportional hazards models from survey data, Biometrika Trust, 79, 139, 10.1093/biomet/79.1.139 Vesikari, 2006, Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine, N Engl J Med, 354, 23, 10.1056/NEJMoa052664 Boom, 2010, Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital, Pediatr Infect Dis J, 29, 1133, 10.1097/INF.0b013e3181ed18ab Weinberg, 2010, Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap, J Infect Dis, 201, 1607, 10.1086/652404 Moulton, 1995, Case-cohort analysis of case-coverage studies of vaccine effectiveness, Am J Epidemiol, 142, 1000, 10.1093/oxfordjournals.aje.a117730 Smith, 2004, Children who have received no vaccines: who are they and where do they live?, Pediatrics, 114, 187, 10.1542/peds.114.1.187 Rotavirus vaccination coverage among infants aged 5 months – immunization information system sentinel sites, United States, June 2006–June 2009. MMWR – Morbidity and mortality weekly report 2010;59(May (17)):521–4. Dennehy, 1990, Choice of reference assay for the detection of rotavirus in fecal specimens: electron microscopy versus enzyme immunoassay, J Clin Microbiol, 28, 1280, 10.1128/JCM.28.6.1280-1283.1990